[Postoperative use of Aldadiene potassium in patients with alloplastic heart valve prosthesis].
D000136:Acid-Base Equilibrium; D001021:Aortic Valve / Q000601:surgery; D001639:Bicarbonates / Q000097:blood; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006350:Heart Valve Prosthesis; D006801:Humans; D008353:Mannitol / Q000627:therapeutic use; D008943:Mitral Valve / Q000601:surgery; D011183:Postoperative Complications / Q000517:prevention & control*; D011188:Potassium / Q000097:blood; D011300:Preoperative Care; D012964:Sodium / Q000097:blood; D013148:Spironolactone / Q000627:therapeutic use*; D014882:Water-Electrolyte Balance
D001639:Bicarbonates; D013148:Spironolactone; D008353:Mannitol; D005665:Furosemide; D012964:Sodium; D004976:Ethacrynic Acid; D011188:Potassium
Zur postoperativen Anwendung von Aldadiene-Kalium bei Patienten mit alloplastischem Herzklappenersatz